Loading stock chart…

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Historical prices through 2026-10-08Latest fiscal period 2025-12-31

Price & fundamentals

Export data/plot:

Timeframe

Compound Annual Growth Rate(CAGR)

—Drag a handle to resize, or the inner selected area to move all five windows—

Detailed metric definitions →

Historical valuation multiples

Export data/plot:

Timeframe

Show P/E 15× / 20× / 30× reference lines

Drag a handle to resize, or the inner selected area to move all five windows

Detailed metric definitions →

Ratio observations in the selected window

Price date	EPS fiscal end	Basic P/E (×)	Diluted P/E (×)	P/S (×)	P/FCF (×)

Profit margins

Export data/plot:

Timeframe

Drag a handle to resize, or the inner selected area to move all five windows

Calculation inputs, filings & unavailable observations

Detailed metric definitions →

Yield, cash conversion & capital returns

Export data/plot:

Timeframe

Drag a handle to resize, or the inner selected area to move all five windows

Calculation inputs, filings & unavailable observations

Detailed metric definitions →

Price & growth-based reference

Export data/plot:

Compound Annual Growth Rate (CAGR)—Selected window

Growth-based P/E—

Formula: min(60, 15 × ((1 + CAGR / 100) / 1.10)^{years × 0.6})

Timeframe

Drag a handle to resize, or the inner selected area to move all five windows

Detailed metric definitions →

Annual change in the selected reference metric

YEAR-OVER-YEAR

Annual metric change

Change from the previous reported fiscal year

Increase Decrease

Annual data and sources

Show annual tables and sources

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) · NYSE · USD · Sector unavailable · SEC ID 0000818686

Annual coverage: 2015-12-31–2025-12-31 (11 periods). Data snapshot built 2026-10-09.

Tables include every stored fiscal period, even outside the selected chart range. Missing or unsupported values are marked “Unavailable,” not zero.

Earnings and per-share history

Annual EPS, cash flow and dividends

Per-share values are in USD; dividend yield is a percent.

Dividend-yield method and limitations

Annual EPS, cash flow, dividends and fiscal-year dividend yield for TEVA PHARMACEUTICAL INDUSTRIES LTD. Per-share values in USD; yield in percent.
Fiscal year / end	Basic EPS	Diluted EPS	FCF / share	Dividends / share	Fiscal-year dividend yield	Filing sources
2025 2025-12-31	1.23	1.21	0.99	Unavailable	Unavailable	Basic EPS (2026-02-03) Diluted EPS (2026-02-03) Operating cash flow (2026-02-03) · Capital expenditure (2026-02-03)
2024 2024-12-31	-1.45	-1.45	0.66	Unavailable	Unavailable	Basic EPS (2026-02-03) Diluted EPS (2026-02-03) Operating cash flow (2026-02-03) · Capital expenditure (2026-02-03)
2023 2023-12-31	-0.50	-0.50	0.75	Unavailable	Unavailable	Basic EPS (2026-02-03) Diluted EPS (2026-02-03) Operating cash flow (2026-02-03) · Capital expenditure (2026-02-03)
2022 2022-12-31	-2.20	-2.20	0.94	Unavailable	Unavailable	Basic EPS (2025-02-05) Diluted EPS (2025-02-05) Operating cash flow (2025-02-05) · Capital expenditure (2023-02-10)
2021 2021-12-31	0.38	0.38	0.21	Unavailable	Unavailable	Basic EPS (2024-02-12) Diluted EPS (2024-02-12) Operating cash flow (2024-02-12) · Capital expenditure (2023-02-10)
2020 2020-12-31	-3.64	-3.64	0.58	Unavailable	Unavailable	Basic EPS (2023-02-10) Diluted EPS (2023-02-10) Operating cash flow (2023-02-10) · Capital expenditure (2023-02-10)
2019 2019-12-31	-0.91	-0.91	0.20	0.00	0.00%	Basic EPS (2022-02-09) Diluted EPS (2022-02-09) Operating cash flow (2022-02-09) · Capital expenditure (2022-02-09) Dividend (2020-02-21)
2018 2018-12-31	-2.35	-2.35	1.76	0.00	0.00%	Basic EPS (2021-02-10) Diluted EPS (2021-02-10) Operating cash flow (2021-02-10) · Capital expenditure (2021-02-10) Dividend (2020-02-21)
2017 2017-12-31	-16.26	-16.26	1.33	0.85	4.49%	Basic EPS (2020-02-21) Diluted EPS (2020-02-21) Operating cash flow (2020-02-21) · Capital expenditure (2020-02-21) Dividend (2020-02-21)
2016 2016-12-31	0.07	0.07	3,110,301.77	1.36	3.86%	Basic EPS (2019-02-19) Diluted EPS (2019-02-19) Operating cash flow (2019-02-19) · Capital expenditure (2019-02-19) Dividend (2019-02-19)
2015 2015-12-31	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source unavailable

Revenue and debt per share

Revenue/share is annual revenue divided by average diluted shares. Debt/share is year-end borrowings divided by common shares; leases are excluded. Per-share values are in USD. Metric definitions.

Fiscal end	Revenue / share	Total debt / share	Calculation inputs & SEC filings
2025-12-31	14.84	Unavailable	Calculation inputs & SEC filings Revenue: 17,258,000,000.00 USD Average diluted shares: 1,163,000,000.00 shares Borrowings: Unavailable — required inputs are missing, conflicting or unsupported Year-end common shares: 1,149,812,898.00 shares Revenue (2026-02-03) · Average diluted shares (2026-02-03) · Year-end common shares (2026-02-03)
2024-12-31	14.63	Unavailable	Calculation inputs & SEC filings Revenue: 16,544,000,000.00 USD Average diluted shares: 1,131,000,000.00 shares Borrowings: Unavailable — required inputs are missing, conflicting or unsupported Year-end common shares: 1,133,838,689.00 shares Revenue (2026-02-03) · Average diluted shares (2026-02-03) · Year-end common shares (2025-02-05)
2023-12-31	14.16	Unavailable	Calculation inputs & SEC filings Revenue: 15,846,000,000.00 USD Average diluted shares: 1,119,000,000.00 shares Borrowings: Unavailable — required inputs are missing, conflicting or unsupported Year-end common shares: 1,121,094,011.00 shares Revenue (2026-02-03) · Average diluted shares (2026-02-03) · Year-end common shares (2024-02-12)
2022-12-31	13.45	Unavailable	Calculation inputs & SEC filings Revenue: 14,925,000,000.00 USD Average diluted shares: 1,110,000,000.00 shares Borrowings: Unavailable — required inputs are missing, conflicting or unsupported Year-end common shares: 1,110,899,783.00 shares Revenue (2025-02-05) · Average diluted shares (2025-02-05) · Year-end common shares (2023-02-10)
2021-12-31	14.34	Unavailable	Calculation inputs & SEC filings Revenue: 15,878,000,000.00 USD Average diluted shares: 1,107,000,000.00 shares Borrowings: Unavailable — required inputs are missing, conflicting or unsupported Year-end common shares: 1,103,329,696.00 shares Revenue (2024-02-12) · Average diluted shares (2024-02-12) · Year-end common shares (2022-02-09)
2020-12-31	15.21	Unavailable	Calculation inputs & SEC filings Revenue: 16,659,000,000.00 USD Average diluted shares: 1,095,000,000.00 shares Borrowings: Unavailable — required inputs are missing, conflicting or unsupported Year-end common shares: 1,096,511,852.00 shares Revenue (2023-02-10) · Average diluted shares (2023-02-10) · Year-end common shares (2021-02-10)
2019-12-31	15.48	Unavailable	Calculation inputs & SEC filings Revenue: 16,887,000,000.00 USD Average diluted shares: 1,091,000,000.00 shares Borrowings: Unavailable — required inputs are missing, conflicting or unsupported Year-end common shares: 1,092,189,007.00 shares Revenue (2022-02-09) · Average diluted shares (2022-02-09) · Year-end common shares (2020-02-21)
2018-12-31	17.90	Unavailable	Calculation inputs & SEC filings Revenue: 18,271,000,000.00 USD Average diluted shares: 1,021,000,000.00 shares Borrowings: Unavailable — required inputs are missing, conflicting or unsupported Year-end common shares: 1,089,388,686.00 shares Revenue (2021-02-10) · Average diluted shares (2021-02-10) · Year-end common shares (2019-02-19)
2017-12-31	21.51	Unavailable	Calculation inputs & SEC filings Revenue: 21,853,000,000.00 USD Average diluted shares: 1,016,000,000.00 shares Borrowings: Unavailable — required inputs are missing, conflicting or unsupported Year-end common shares: Unavailable — required inputs are missing, conflicting or unsupported Revenue (2020-02-21) · Average diluted shares (2020-02-21)
2016-12-31	22,791,883.45	Unavailable	Calculation inputs & SEC filings Revenue: 21,903,000,000.00 USD Average diluted shares: 961.00 shares Borrowings: Unavailable — required inputs are missing, conflicting or unsupported Year-end common shares: 1,123,402,689.00 shares Revenue (2019-02-19) · Average diluted shares (2019-02-19) · Year-end common shares (2018-02-12)
2015-12-31	Unavailable	Unavailable	Calculation inputs & SEC filings Revenue: 19,652,000,000.00 USD Average diluted shares: Unavailable — required inputs are missing, conflicting or unsupported Borrowings: Unavailable — required inputs are missing, conflicting or unsupported Year-end common shares: Unavailable — required inputs are missing, conflicting or unsupported Revenue (2018-02-12)

Operating performance and returns

Revenue and profit margins

Operating margin is operating income divided by revenue; net margin is net income divided by revenue. Negative margins indicate a loss. Metric definitions.

Fiscal end	Revenue (USD)	Operating margin (%)	Net margin (%)	Calculation inputs & SEC filings
2025-12-31	17,258,000,000.00	12.50	8.22	Calculation inputs & SEC filings Revenue: 17,258,000,000.00 USD Operating income: 2,157,000,000.00 USD Net income: 1,418,000,000.00 USD Revenue (2026-02-03) · Operating income (2026-02-03) · Net income (2026-02-03)
2024-12-31	16,544,000,000.00	-1.83	-11.84	Calculation inputs & SEC filings Revenue: 16,544,000,000.00 USD Operating income: -303,000,000.00 USD Net income: -1,959,000,000.00 USD Revenue (2026-02-03) · Operating income (2026-02-03) · Net income (2026-02-03)
2023-12-31	15,846,000,000.00	2.73	-3.88	Calculation inputs & SEC filings Revenue: 15,846,000,000.00 USD Operating income: 433,000,000.00 USD Net income: -615,000,000.00 USD Revenue (2026-02-03) · Operating income (2026-02-03) · Net income (2026-02-03)
2022-12-31	14,925,000,000.00	-14.72	-16.74	Calculation inputs & SEC filings Revenue: 14,925,000,000.00 USD Operating income: -2,197,000,000.00 USD Net income: -2,499,000,000.00 USD Revenue (2025-02-05) · Operating income (2025-02-05) · Net income (2025-02-05)
2021-12-31	15,878,000,000.00	10.81	2.87	Calculation inputs & SEC filings Revenue: 15,878,000,000.00 USD Operating income: 1,716,000,000.00 USD Net income: 456,000,000.00 USD Revenue (2024-02-12) · Operating income (2024-02-12) · Net income (2024-02-12)
2020-12-31	16,659,000,000.00	-21.44	-24.61	Calculation inputs & SEC filings Revenue: 16,659,000,000.00 USD Operating income: -3,572,000,000.00 USD Net income: -4,099,000,000.00 USD Revenue (2023-02-10) · Operating income (2023-02-10) · Net income (2023-02-10)
2019-12-31	16,887,000,000.00	-2.62	-5.92	Calculation inputs & SEC filings Revenue: 16,887,000,000.00 USD Operating income: -443,000,000.00 USD Net income: -1,000,000,000.00 USD Revenue (2022-02-09) · Operating income (2022-02-09) · Net income (2022-02-09)
2018-12-31	18,271,000,000.00	-8.96	-13.53	Calculation inputs & SEC filings Revenue: 18,271,000,000.00 USD Operating income: -1,637,000,000.00 USD Net income: -2,472,000,000.00 USD Revenue (2021-02-10) · Operating income (2021-02-10) · Net income (2021-02-10)
2017-12-31	21,853,000,000.00	-80.01	-75.27	Calculation inputs & SEC filings Revenue: 21,853,000,000.00 USD Operating income: -17,484,000,000.00 USD Net income: -16,449,000,000.00 USD Revenue (2020-02-21) · Operating income (2020-02-21) · Net income (2020-02-21)
2016-12-31	21,903,000,000.00	9.83	1.42	Calculation inputs & SEC filings Revenue: 21,903,000,000.00 USD Operating income: 2,154,000,000.00 USD Net income: 311,000,000.00 USD Revenue (2019-02-19) · Operating income (2019-02-19) · Net income (2019-02-19)
2015-12-31	19,652,000,000.00	17.06	8.13	Calculation inputs & SEC filings Revenue: 19,652,000,000.00 USD Operating income: 3,352,000,000.00 USD Net income: 1,597,000,000.00 USD Revenue (2018-02-12) · Operating income (2018-02-12) · Net income (2018-02-12)

Cash generation and capital returns

FCF margin is free cash flow as a share of revenue. FCF / net income compares free cash flow with positive net income. ROCE divides operating income by average capital employed and requires positive opening and closing balances. Metric definitions.

Fiscal end	FCF margin (%)	FCF / net income (%)	ROCE (%)	Calculation inputs & SEC filings
2025-12-31	6.65	80.96	8.02	Calculation inputs & SEC filings FCF margin (FCF ÷ revenue): Free cash flow 1,148,000,000.00 USD ÷ Revenue 17,258,000,000.00 USD FCF / net income: Free cash flow 1,148,000,000.00 USD ÷ Net income 1,418,000,000.00 USD ROCE (operating income ÷ average capital employed): Operating income 2,157,000,000.00 USD ÷ Average capital employed 26,911,000,000.00 USD Operating cash flow (2026-02-03) · Capital expenditure (2026-02-03) · Revenue (2026-02-03) · Operating cash flow (2026-02-03) · Capital expenditure (2026-02-03) · FCF / net income input 3 (2026-02-03) · Operating income (2026-02-03) · Total assets as of 2024-12-31 (2026-02-03) · Current liabilities as of 2024-12-31 (2026-02-03) · Total assets as of 2025-12-31 (2026-02-03) · Current liabilities as of 2025-12-31 (2026-02-03)
2024-12-31	4.53	Unavailable	-1.05	Calculation inputs & SEC filings FCF margin (FCF ÷ revenue): Free cash flow 749,000,000.00 USD ÷ Revenue 16,544,000,000.00 USD FCF / net income: Unavailable — required inputs are missing, conflicting or unsupported. ROCE (operating income ÷ average capital employed): Operating income -303,000,000.00 USD ÷ Average capital employed 28,881,000,000.00 USD Operating cash flow (2026-02-03) · Capital expenditure (2026-02-03) · Revenue (2026-02-03) · Operating cash flow (2026-02-03) · Capital expenditure (2026-02-03) · FCF / net income input 3 (2026-02-03) · Operating income (2026-02-03) · Total assets as of 2023-12-31 (2025-02-05) · Current liabilities as of 2023-12-31 (2025-02-05) · Total assets as of 2024-12-31 (2026-02-03) · Current liabilities as of 2024-12-31 (2026-02-03)
2023-12-31	5.31	Unavailable	1.36	Calculation inputs & SEC filings FCF margin (FCF ÷ revenue): Free cash flow 842,000,000.00 USD ÷ Revenue 15,846,000,000.00 USD FCF / net income: Unavailable — required inputs are missing, conflicting or unsupported. ROCE (operating income ÷ average capital employed): Operating income 433,000,000.00 USD ÷ Average capital employed 31,887,000,000.00 USD Operating cash flow (2026-02-03) · Capital expenditure (2026-02-03) · Revenue (2026-02-03) · Operating cash flow (2026-02-03) · Capital expenditure (2026-02-03) · FCF / net income input 3 (2026-02-03) · Operating income (2026-02-03) · Total assets as of 2022-12-31 (2024-02-12) · Current liabilities as of 2022-12-31 (2024-02-12) · Total assets as of 2023-12-31 (2025-02-05) · Current liabilities as of 2023-12-31 (2025-02-05)
2022-12-31	6.98	Unavailable	-6.35	Calculation inputs & SEC filings FCF margin (FCF ÷ revenue): Free cash flow 1,042,000,000.00 USD ÷ Revenue 14,925,000,000.00 USD FCF / net income: Unavailable — required inputs are missing, conflicting or unsupported. ROCE (operating income ÷ average capital employed): Operating income -2,197,000,000.00 USD ÷ Average capital employed 34,590,500,000.00 USD Operating cash flow (2023-02-10) · Capital expenditure (2023-02-10) · Revenue (2023-02-10) · Operating cash flow (2025-02-05) · Capital expenditure (2023-02-10) · FCF / net income input 3 (2025-02-05) · Operating income (2025-02-05) · Total assets as of 2021-12-31 (2023-02-10) · Current liabilities as of 2021-12-31 (2023-02-10) · Total assets as of 2022-12-31 (2024-02-12) · Current liabilities as of 2022-12-31 (2024-02-12)
2021-12-31	1.49	51.75	4.63	Calculation inputs & SEC filings FCF margin (FCF ÷ revenue): Free cash flow 236,000,000.00 USD ÷ Revenue 15,878,000,000.00 USD FCF / net income: Free cash flow 236,000,000.00 USD ÷ Net income 456,000,000.00 USD ROCE (operating income ÷ average capital employed): Operating income 1,716,000,000.00 USD ÷ Average capital employed 37,057,500,000.00 USD Operating cash flow (2023-02-10) · Capital expenditure (2023-02-10) · Revenue (2023-02-10) · Operating cash flow (2023-02-10) · Capital expenditure (2023-02-10) · FCF / net income input 3 (2023-02-10) · Operating income (2024-02-12) · Total assets as of 2020-12-31 (2022-02-09) · Current liabilities as of 2020-12-31 (2022-02-09) · Total assets as of 2021-12-31 (2023-02-10) · Current liabilities as of 2021-12-31 (2023-02-10)
2020-12-31	3.83	Unavailable	-8.79	Calculation inputs & SEC filings FCF margin (FCF ÷ revenue): Free cash flow 638,000,000.00 USD ÷ Revenue 16,659,000,000.00 USD FCF / net income: Unavailable — required inputs are missing, conflicting or unsupported. ROCE (operating income ÷ average capital employed): Operating income -3,572,000,000.00 USD ÷ Average capital employed 40,636,000,000.00 USD Operating cash flow (2023-02-10) · Capital expenditure (2023-02-10) · Revenue (2023-02-10) · Operating cash flow (2023-02-10) · Capital expenditure (2023-02-10) · FCF / net income input 3 (2023-02-10) · Operating income (2023-02-10) · Total assets as of 2019-12-31 (2021-02-10) · Current liabilities as of 2019-12-31 (2021-02-10) · Total assets as of 2020-12-31 (2022-02-09) · Current liabilities as of 2020-12-31 (2022-02-09)
2019-12-31	1.32	Unavailable	-0.98	Calculation inputs & SEC filings FCF margin (FCF ÷ revenue): Free cash flow 223,000,000.00 USD ÷ Revenue 16,887,000,000.00 USD FCF / net income: Unavailable — required inputs are missing, conflicting or unsupported. ROCE (operating income ÷ average capital employed): Operating income -443,000,000.00 USD ÷ Average capital employed 45,078,500,000.00 USD Operating cash flow (2022-02-09) · Capital expenditure (2022-02-09) · Revenue (2022-02-09) · Operating cash flow (2022-02-09) · Capital expenditure (2022-02-09) · FCF / net income input 3 (2022-02-09) · Operating income (2022-02-09) · Total assets as of 2018-12-31 (2020-02-21) · Current liabilities as of 2018-12-31 (2020-02-21) · Total assets as of 2019-12-31 (2021-02-10) · Current liabilities as of 2019-12-31 (2021-02-10)
2018-12-31	9.82	Unavailable	-3.31	Calculation inputs & SEC filings FCF margin (FCF ÷ revenue): Free cash flow 1,795,000,000.00 USD ÷ Revenue 18,271,000,000.00 USD FCF / net income: Unavailable — required inputs are missing, conflicting or unsupported. ROCE (operating income ÷ average capital employed): Operating income -1,637,000,000.00 USD ÷ Average capital employed 49,527,500,000.00 USD Operating cash flow (2021-02-10) · Capital expenditure (2021-02-10) · Revenue (2021-02-10) · Operating cash flow (2021-02-10) · Capital expenditure (2021-02-10) · FCF / net income input 3 (2021-02-10) · Operating income (2021-02-10) · Total assets as of 2017-12-31 (2019-02-19) · Current liabilities as of 2017-12-31 (2019-02-19) · Total assets as of 2018-12-31 (2020-02-21) · Current liabilities as of 2018-12-31 (2020-02-21)
2017-12-31	6.18	Unavailable	-27.48	Calculation inputs & SEC filings FCF margin (FCF ÷ revenue): Free cash flow 1,351,000,000.00 USD ÷ Revenue 21,853,000,000.00 USD FCF / net income: Unavailable — required inputs are missing, conflicting or unsupported. ROCE (operating income ÷ average capital employed): Operating income -17,484,000,000.00 USD ÷ Average capital employed 63,631,500,000.00 USD Operating cash flow (2020-02-21) · Capital expenditure (2020-02-21) · Revenue (2020-02-21) · Operating cash flow (2020-02-21) · Capital expenditure (2020-02-21) · FCF / net income input 3 (2020-02-21) · Operating income (2020-02-21) · Total assets as of 2016-12-31 (2018-02-12) · Current liabilities as of 2016-12-31 (2018-02-12) · Total assets as of 2017-12-31 (2019-02-19) · Current liabilities as of 2017-12-31 (2019-02-19)
2016-12-31	13.65	961.09	Unavailable	Calculation inputs & SEC filings FCF margin (FCF ÷ revenue): Free cash flow 2,989,000,000.00 USD ÷ Revenue 21,903,000,000.00 USD FCF / net income: Free cash flow 2,989,000,000.00 USD ÷ Net income 311,000,000.00 USD ROCE (operating income ÷ average capital employed): Unavailable — required balance-sheet inputs are missing or inconsistent. Operating cash flow (2019-02-19) · Capital expenditure (2019-02-19) · Revenue (2019-02-19) · Operating cash flow (2019-02-19) · Capital expenditure (2019-02-19) · FCF / net income input 3 (2019-02-19) · Operating income (2019-02-19) · Total assets as of 2016-12-31 (2018-02-12) · Current liabilities as of 2016-12-31 (2018-02-12)
2015-12-31	Unavailable	Unavailable	Unavailable	Calculation inputs & SEC filings FCF margin (FCF ÷ revenue): Unavailable — required inputs are missing, conflicting or unsupported. FCF / net income: Unavailable — required inputs are missing, conflicting or unsupported. ROCE (operating income ÷ average capital employed): Unavailable — required balance-sheet inputs are missing or inconsistent. Revenue (2018-02-12) · FCF / net income input 1 (2018-02-12) · Operating income (2018-02-12)

Valuation history

P/E ratio history

The P/E chart uses 1305 weekly price points (2001-10-12–2026-10-08); 146 have a basic or diluted P/E ratio. Annual EPS carries forward between fiscal year-ends.

Fiscal-year-end snapshots

3 fiscal-year-end periods with an eligible ratio (2016-12-31–2025-12-31). Most recent: diluted 26.36× and basic 25.93× (fiscal end 2025-12-31; price date 2025-12-26).

Annual P/E = fiscal-year-end closing price ÷ reported annual EPS. It is a historical annual ratio, not TTM or forward P/E. Zero or negative EPS and missing eligible prices produce no ratio. Why we use annual data.

Open the interactive P/E chart · How P/E history is calculated.

Show all annual P/E values (11 fiscal years)

Full stored fiscal-year-end P/E history, independent of the selected chart window. Ratios in ×; prices in USD.
Fiscal end	Price date	Close	Price basis	Basic P/E	Diluted P/E	EPS filings
2025-12-31	2025-12-26	31.89	Adjusted close	25.93	26.36	Basic EPS (2026-02-03) Diluted EPS (2026-02-03)
2024-12-31	2024-12-27	22.77	Adjusted close	Unavailable	Unavailable	Basic EPS (2026-02-03) Diluted EPS (2026-02-03)
2023-12-31	2023-12-29	10.44	Adjusted close	Unavailable	Unavailable	Basic EPS (2026-02-03) Diluted EPS (2026-02-03)
2022-12-31	2022-12-30	9.12	Adjusted close	Unavailable	Unavailable	Basic EPS (2025-02-05) Diluted EPS (2025-02-05)
2021-12-31	2021-12-31	8.01	Adjusted close	21.08	21.08	Basic EPS (2024-02-12) Diluted EPS (2024-02-12)
2020-12-31	2020-12-31	9.65	Adjusted close	Unavailable	Unavailable	Basic EPS (2023-02-10) Diluted EPS (2023-02-10)
2019-12-31	2019-12-27	9.96	Adjusted close	Unavailable	Unavailable	Basic EPS (2022-02-09) Diluted EPS (2022-02-09)
2018-12-31	2018-12-28	15.69	Adjusted close	Unavailable	Unavailable	Basic EPS (2021-02-10) Diluted EPS (2021-02-10)
2017-12-31	2017-12-29	18.95	Adjusted close	Unavailable	Unavailable	Basic EPS (2020-02-21) Diluted EPS (2020-02-21)
2016-12-31	2016-12-30	35.25	Adjusted close	503.59	503.59	Basic EPS (2019-02-19) Diluted EPS (2019-02-19)
2015-12-31	2015-12-31	62.32	Adjusted close	Unavailable	Unavailable	Source unavailable

Did this research save you time?

I build and maintain Stock Value Lens independently. If you found it useful, a coffee helps me maintain the tools and improve data updates.

Buy me a coffee · €5